7,016,312 Shares of Common Stock Pre-Funded Warrants to Purchase Up to 3,483,688 Shares of Common Stock ($0.001 par value per share) KalVista Pharmaceuticals, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • February 16th, 2024 • KalVista Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 16th, 2024 Company Industry Jurisdiction